Tag Archives: BIO EVENT

Fireside Chat: “Everything we knew in science 10 years ago is wrong.”


The speed of scientific innovation these days is comparable to the PC innovation era of the 1980s, according to Robert Nelsen of ARCH Venture Partners at today’s BIO Investor Forum fireside chat. This is not to say that he feels investing in biopharma is a short term game. Robert urged the audience to “keep their faith” in good science and the “good ideas will percolate up” to yield innovative breakthroughs. Having played a significant role Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Stretching Your Dollar: Methods and Tools for Increasing the Productivity of Clinical Trials


Recent Tufts data show clinical trials typically take nearly twice as long to complete enrollment as predicted at launch and 48% of trial sites miss enrollment targets.  Delays in trials shrink the returns from patent exclusivity and increase R&D costs.  New methods such as adaptive and batch trial designs, as well as explosive growth in digital tools, such as Apple’s ResearchKit, have transformed the trial design choices available.  These innovations, and others, provide new levers Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Welcome to Montreal and to the 2015 BIO World Congress


Welcome to Montreal and to the 12th Annual BIO World Congress on Industrial Biotechnology. The theme of this conference is linking chemistry, biotechnology and agriculture to create new value chains.  That is what BIO is all about – bringing thought leaders, researchers and venture capitalists together and fostering R&D and business development opportunities that will allow us to further the important goal of creating the value chains that are the lifeblood of the biobased economy. At BIO, Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How to Grow a Sustainable Biotech Company? Three Success Stories

Sustainable Biotech Company

Katrine Bosley, CEO of Editas Medicine kicked off the session by introducing panelists from three biotech firms with drug candidates in various stages: Arndt Schottelius, CDO of MorphoSys,  Loredana Ablondi, Licensing Manager of Chiesi Farmaceutici SpA (Cheisi) and Andre Hoekema, Senior Vice President of Corporate Development at Galapagos NV. The panelists spoke about the importance of critical alliances which enabled them to grow their companies, and the possibilities that emerged from them. For MorphaSys, this Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Scientific American WorldView Super Session and the Future of Innovation


The final Super Session of the 2015 BIO International Convention today featured a panel of international luminaries who offered their perspective on the future of innovation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, the panelists provided a fresh perspectives on international life science development and the ways disruptive technologies are changing how we do business and experience the world around us. On the panel: Lee Hood, President of Institute Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,